Showing results (2141-2150 of 2,613) with videos related to
Sort By:
Pageof 262
Journal of Medicinal Chemistry|March 23, 2011
5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2)Peter T Sunderland, Esther C Y Woon, Archana Dhami, et al.Bioorganic & Medicinal Chemistry|December 8, 2004
Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonistsJohn W Huffman, Gulay Zengin, Ming-Jung Wu, et al.Hepatology (Baltimore, Md.)|September 12, 2013
Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion releaseToshana L Foster, Gary S Thompson, Arnout P Kalverda, et al.Current Protocols in Human Genetics|October 12, 2016
COSMIC: High-Resolution Cancer Genetics Using the Catalogue of Somatic Mutations in CancerS A Forbes, D Beare, N Bindal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2013
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancerTarrik M Zaid, Tsz-Lun Yeung, Melissa S Thompson, et al.JACC. Heart Failure|October 15, 2018
Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD TrialColleen K McIlvennan, Daniel D Matlock, Jocelyn S Thompson, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 20, 2020
Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge TrialDaniel D Matlock, Colleen K McIlvennan, Jocelyn S Thompson, et al.Nature|July 8, 2005
Aeolian processes at the Mars Exploration Rover Meridiani Planum landing siteR Sullivan, D Banfield, J F Bell, et al.Diabetes|June 21, 2014
Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat-fed miceLi Kang, Chunhua Dai, Mary E Lustig, et al.Ocular Immunology and Inflammation|June 15, 2007
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's diseaseRonald R Buggage, Grace Levy-Clarke, Hatice N Sen, et al.Pageof 262